S
Sanja Koštrun
Researcher at GlaxoSmithKline
Publications - 24
Citations - 433
Sanja Koštrun is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: Oleandomycin & Desosamine. The author has an hindex of 11, co-authored 24 publications receiving 351 citations. Previous affiliations of Sanja Koštrun include Leibniz Association & University of Manchester.
Papers
More filters
Journal ArticleDOI
Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer.
Andrea Bistrović,Luka Krstulović,Anja Harej,Petra Grbčić,Mirela Sedić,Sanja Koštrun,Sandra Kraljević Pavelić,Miroslav Bajić,Silvana Raić-Malić +8 more
TL;DR: Western blot analyses showed different mechanisms of cytostatic activity between compounds 10c and 11f that could be associated with the nature of aromatic substituent at 1-(1,2,3-triazolyl) and amidino moiety at C-5 position of benzimidazole ring.
Journal ArticleDOI
Modeling cellular pharmacokinetics of 14- and 15-membered macrolides with physicochemical properties.
Višnja Stepanić,Sanja Koštrun,Ivica Malnar,Mario Hlevnjak,Kristina Butković,Irena Ćaleta,Marko Dukši,Goran Kragol,Oresta Makaruha-Stegić,Lara Mikac,Jovica Ralić,Iva Tatić,Branka Tavčar,Klára Valkó,Selvira Zulfikari,Vesna Munić +15 more
TL;DR: The development of the first models for macrolide cellular pharmacokinetics was described, using relatively easily determined and conceptually simple descriptors: experimentally determined physicochemical parameters ChromlogD and CHI IAM, as well as a calculated number of positively charged atoms (POS).
Journal ArticleDOI
Intensity of macrolide anti-inflammatory activity in J774A.1 cells positively correlates with cellular accumulation and phospholipidosis.
Vesna Munić,Mihailo Banjanac,Sanja Koštrun,Krunoslav Nujić,Martina Bosnar,Nikola Marjanović,Jovica Ralić,Mario Matijašić,Mario Hlevnjak,Vesna Eraković Haber +9 more
TL;DR: It is concluded that LPS-stimulated J774A.1 cells in presented experimental setup are not a representative cellular model for the evaluation of macrolide anti-inflammatory potential in clinical trials, and shows that, at least in in vitro models, binding to biological membranes may be the crucial factor of Macrolide mechanism of action.
Journal ArticleDOI
Homology modeling of human Fyn kinase structure: discovery of rosmarinic acid as a new Fyn kinase inhibitor and in silico study of its possible binding modes.
Dubravko Jelić,Boris Mildner,Sanja Koštrun,Krunoslav Nujić,Donatella Verbanac,Ognjen Čulić,Roberto Antolović,Wolfgang Brandt +7 more
TL;DR: The three-dimensional structure of Fyn tyrosine kinase, a Src-family enzyme involved in T-cell receptor signal transduction, is presented and it is revealed that Fyn is inhibited by a linear-mixed noncompetitive mechanism of inhibition by rosmarinic acid.
Journal ArticleDOI
Physicochemical profile of macrolides and their comparison with small molecules
Višnja Stepanić,Višnja Stepanić,Dinko Žiher,Vesna Gabelica-Marković,Dubravko Jelić,Shenaz Nunhuck,Klára Valkó,Sanja Koštrun +7 more
TL;DR: It has been found that macrolides and small molecules have similar lipophilicity profiles, though macrolide show weaker PPB and have better solubility than small discovery molecules.